Glaucoma Clinical Trials in Long Beach, CA

Glaucoma Clinical Trials in Long Beach, CA

View the best 10 glaucoma medical studies in Long Beach, California. Access promising new therapies by applying to a Long Beach-based Glaucoma clinical trial.

Trials in Long Beach, California

Here are the top 10 medical studies for glaucoma in Long Beach, California

Michael Bask Gill, B Sc preview

Michael Bask Gill, B Sc

Last Reviewed: August 21st, 2024

Image of Ocular Therapeutiux, Inc. in Delray Beach, United States.

OTX-TIC low dose Travoprost Intracameral Implant +2 More

Prostaglandin Analog

Recruiting3 awardsPhase 2
This trial tests a small device that releases medication inside the eye to help patients with high eye pressure due to glaucoma or ocular hypertension. The medication helps fluid drain from the eye, reducing pressure and preventing vision problems.
Image of Global Research Management, Inc. in Glendale, United States.

T4090 +1 More

Procedure

Recruiting1 awardPhase 2
This trial aims to compare the effectiveness and safety of two different concentrations of T4090 eye drops (0.2% and 0.3%) with Rhopressa® eye drops in reducing
Image of NCT01520116 in Artesia, United States.

ATS907

Recruiting1 awardPhase 1 & 2
This trial will compare the safety and effectiveness of ATS907 to latanoprost, a similar medication, in people with glaucoma or ocular hypertension.
Image of Eye Research Foundation in Newport Beach, United States.

Latanoprost 0.005% +1 More

Prostaglandin Analog

Recruiting2 awardsPhase 3
This trial is testing NCX 470 eye drops to see if they can safely and effectively lower eye pressure in people with high eye pressure or glaucoma. The goal is to protect their vision by reducing the pressure inside their eyes. NCX 470 is a nitric oxide (NO)-donating bimatoprost with clinically demonstrated pressure-lowering effects.
Image of United Medical Research Institute in Inglewood, United States.

Latanoprost +2 More

Prostaglandin Analogues

Recruiting0 awardsPhase 2
"This trial aims to test the safety and effectiveness of two different eye drops in people with open-angle glaucoma or high eye pressure."
Image of Eye Research Foundation in Newport Beach, United States.

AMDX-2011P

Procedure

Recruiting1 awardPhase 2
This trial aims to determine if AMDX-2011P can be used to detect amyloid deposits in the retina of individuals with Primary Open Angle Glaucoma (POAG).
Image of Sacramento Eye Consultants, A Medical Corporation in Sacramento, United States.

Hydrus Microstent +2 More

Microstent

Recruiting1 award5 criteria
This trial is evaluating the placement and effects of a tiny device called the Hydrus Microstent in patients having cataract surgery. The device helps drain fluid from the eye to reduce pressure. The study will monitor patients over time to see how well the device works and if there are any issues. The Hydrus Microstent is designed to increase fluid drainage from the eye and lower eye pressure.
Image of West Coast Eye Institute in Bakersfield, United States.

Bimatoprost Ophthalmic Solution

Prostaglandin Analog

Recruiting1 awardPhase 1
This trial compares two different treatments to see if they are equivalent, using a method where neither the patients nor the researchers know which treatment is being given.
Image of Dixon Eye Care in Albany, United States.

H-1337 +1 More

Prostaglandin Analog

Recruiting0 awardsPhase 2
This trial is testing different doses of a new eye drop (H-1337) in patients who need treatment in both eyes. The goal is to see if H-1337 is safe and effective. Both treatments work by reducing pressure inside the eyes. The existing treatment has been used for many years but has some issues with how well it works and how easy it is for patients to use.
Image of West Virginia University in Morgantown, United States.

Standard Energy SLT +1 More

Laser Therapy

Recruiting2 awardsPhase 3
This trial is testing if a lower-energy version of a common glaucoma treatment is as effective as the standard treatment, and if repeating the lower-energy treatment yearly is better than waiting for the treatment to wear off.

Popular Filters

Age 65+
Phase 3
< 50 mile distance
No Placebo

Trials With No Placebo

Glendale, California

Procedure

T4090 vs Rhopressa for Glaucoma

Recruiting1 awardPhase 2
Torrance, California
This trial aims to compare the effectiveness and safety of two different concentrations of T4090 eye drops (0.2% and 0.3%) with Rhopressa® eye drops in reducing
Bakersfield, California

Prostaglandin Analog

Bimatoprost Solutions for Glaucoma

Recruiting1 awardPhase 1
Newport Beach, California
This trial compares two different treatments to see if they are equivalent, using a method where neither the patients nor the researchers know which treatment is being given.
Newport Beach, California

Procedure

AMDX-2011P for Glaucoma

Recruiting1 awardPhase 2
Newport Beach, California
This trial aims to determine if AMDX-2011P can be used to detect amyloid deposits in the retina of individuals with Primary Open Angle Glaucoma (POAG).
La Jolla, California

Maestro2 OCT Screening for Glaucoma

Recruiting1 award3 criteria
La Jolla, California
This trial seeks to create a reliable screening process for medical conditions by gathering data from multiple sources.
Ventura, California

Device

XEN45 Gel Stent for Open-Angle Glaucoma

Recruiting2 awardsPhase 3
Ventura, California
This trial will help assess the safety and effectiveness of a glaucoma gel stent when implanted using the ab externo approach.
Delray Beach, Florida

Prostaglandin Analog

Travoprost Implant for Glaucoma

Recruiting3 awardsPhase 2
Torrance, California
This trial tests a small device that releases medication inside the eye to help patients with high eye pressure due to glaucoma or ocular hypertension. The medication helps fluid drain from the eye, reducing pressure and preventing vision problems.

View More Related Trials

AGN-193408 SR

ATS907

View more glaucoma clinical trials long-beach

See more medical studies focusing on glaucoma long-beach

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top